ACTA1 and pulmonary fibrosis: In response to therapeutic AAV5-TP53TG1, the lung tissues of mice showed less fibrotic area, lighter Collagen I and α-SMA staining (Fig. 6f–g), indicating that TP53TG1 is able to impede the progression of lung fibrosis.